# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Morgan Stanley analyst Michael Cyprys maintains Blackstone (NYSE:BX) with a Overweight and raises the price target from $200...
https://www.bloomberg.com/news/articles/2025-10-21/citi-barclays-among-banks-leading-hologic-12-billion-d
Hologic shares rose after announcing an $18.3B buyout by Blackstone and TPG, including a $3 CVR linked to Breast Health revenue...
- SEC Filing
Hologic Stockholders to Receive $76 per Share in Cash Plus a Contingent Value Right of up to $3 per Share Payable Upon Achievin...
https://www.bloomberg.com/news/articles/2025-10-20/blackstone-prices-507-million-cmbs-deal-linked-to-uk-warehouses